We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+15.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$46.2B
AUM Growth
+$4.02B
Cap. Flow
-$2.06B
Cap. Flow %
-4.46%
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33

Top Sells

1
PFE icon
Pfizer
PFE
+$231M
2
BBD icon
Banco Bradesco
BBD
+$182M
3
DOX icon
Amdocs
DOX
+$175M
4
ORCL icon
Oracle
ORCL
+$156M
5
CVX icon
Chevron
CVX
+$145M

Sector Composition

1 Financials 15.39%
2 Technology 14.48%
3 Consumer Discretionary 13.41%
4 Healthcare 10.59%
5 Communication Services 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$315B
$251M 0.54%
3,165,724
-159,822
-5% -$12M
MDLZ icon
52
Mondelez International
MDLZ
$78.8B
$250M 0.54%
5,000,824
-902,498
-15% -$41.4M
HD icon
53
Home Depot
HD
$347B
$249M 0.54%
1,297,422
-173,514
-12% -$31.8M
PFE icon
54
Pfizer
PFE
$143B
$243M 0.53%
6,020,058
-5,770,957
-49% -$231M
DD icon
55
DuPont de Nemours
DD
$18.1B
$240M 0.52%
1,774,693
-480,709
-21% -$66.7M
INTC icon
56
Intel
INTC
$487B
$235M 0.51%
4,371,354
+152,734
+4% +$7.75M
JPM icon
57
JPMorgan Chase
JPM
$912B
$233M 0.5%
2,298,892
+260,201
+13% +$26.8M
SCHW
58
Charles Schwab
SCHW
$179B
$222M 0.48%
5,184,539
+665,391
+15% +$30M
MRVL icon
59
Marvell Technology
MRVL
$169B
$216M 0.47%
10,876,059
-734,165
-6% -$13.7M
MDT icon
60
Medtronic
MDT
$107B
$207M 0.45%
2,273,737
-1,184,526
-34% -$106M
LIN icon
61
Linde
LIN
$241B
$203M 0.44%
+1,152,668
New +$191M
DE icon
62
Deere & Co
DE
$162B
$198M 0.43%
1,241,548
-106,336
-8% -$17M
CME icon
63
CME Group
CME
$89B
$198M 0.43%
1,201,826
-255,180
-18% -$45.1M
NFLX icon
64
Netflix
NFLX
$313B
$194M 0.42%
5,436,850
+3,628,470
+201% +$126M
PG icon
65
Procter & Gamble
PG
$353B
$191M 0.41%
1,831,694
+159,351
+10% +$15.5M
QSR icon
66
Restaurant Brands International
QSR
$26.8B
$189M 0.41%
2,901,309
-631,425
-18% -$38.8M
BMY icon
67
Bristol-Myers Squibb
BMY
$124B
$189M 0.41%
3,953,089
+3,259,004
+470% +$162M
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.06T
$182M 0.39%
905,296
+27,443
+3% +$5.54M
MTB icon
69
M&T Bank
MTB
$36.8B
$180M 0.39%
1,148,977
-101,949
-8% -$16.7M
BURL icon
70
Burlington
BURL
$22.4B
$178M 0.39%
1,136,684
+470,242
+71% +$75.8M
CSX icon
71
CSX Corp
CSX
$94.6B
$176M 0.38%
7,037,238
-5,727,408
-45% -$133M
KO icon
72
Coca-Cola
KO
$365B
$171M 0.37%
3,642,494
+582,317
+19% +$27.2M
CE icon
73
Celanese
CE
$5.02B
$170M 0.37%
1,724,240
-387,587
-18% -$38.1M
CHKP icon
74
Check Point Software Technologies
CHKP
$14.2B
$169M 0.37%
1,332,822
-304,194
-19% -$35.4M
TSM icon
75
TSMC
TSM
$2.13T
$157M 0.34%
3,839,670
-643,855
-14% -$24.6M

Similar funds

Aberdeen Group's Q1 2019 Portfolio in Review

As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Aberdeen Group opened a new position in Linde worth $203M.

  • Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
  • Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
  • Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
  • Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
  • Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
  • Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
  • Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.

Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.